Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.

Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.

Topoisomerase II is critical for DNA replication, transcription and chromosome segregation and is a well validated target of anti-neoplastic drugs including the anthracyclines and epipodophyllotoxins. However, these drugs are limited by common tumor resistance mechanisms and side-effect profiles. No...

Full description

Bibliographic Details
Main Authors:	Rachael E Hawtin, David E Stockett, Jo Ann W Byl, Robert S McDowell, Tan Nguyen, Michelle R Arkin, Andrew Conroy, Wenjin Yang, Neil Osheroff, Judith A Fox
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-04-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC2855444?pdf=render

Similar Items

Actions of a Novel Bacterial Topoisomerase Inhibitor against <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
by: Soziema E. Dauda, et al.
Published: (2023-07-01)

No Time to Relax and Unwind: Exploration of Topoisomerases and a Growing Field of Study
by: Joseph E. Deweese, et al.
Published: (2023-08-01)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
by: Scott Grossman, et al.
Published: (2023-02-01)

Evaluation of the Mutations in Topoisomerase IV Genes and Their Role in Development of Resistance to Quinolones in Streptococcus pneumonia
by: Fataneh Moein Jahromi, et al.
Published: (2019-02-01)

A T5 Exonuclease-Based Assay for DNA Topoisomerases and DNA Intercalators
by: Zifang Deng, et al.
Published: (2021-04-01)

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
by: Faten Farouk, et al.
Published: (2023-12-01)

Direct monitoring of the strand passage reaction of DNA topoisomerase II triggers checkpoint activation.
by: Katherine L Furniss, et al.
Published: (2013-01-01)

DNA topoisomerases as molecular targets for anticancer drugs
by: Kamila Buzun, et al.
Published: (2020-01-01)

Mutational Diversity in the Quinolone Resistance-Determining Regions of Type-II Topoisomerases of <i>Salmonella</i> Serovars
by: Aqsa Shaheen, et al.
Published: (2021-11-01)

Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases
by: Jeffrey Y. Jian, et al.
Published: (2023-07-01)

Breakage-reunion domain of Streptococcus pneumoniae topoisomerase IV: crystal structure of a gram-positive quinolone target.
by: Ivan Laponogov, et al.
Published: (2007-03-01)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
by: Victor M. Matias-Barrios, et al.
Published: (2021-02-01)

Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective
by: Ahmed M. Elshazly, et al.
Published: (2023-12-01)

Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
by: Amol Mehta, et al.
Published: (2018-06-01)

Prognostic Values of Filamin-A Status for Topoisomerase II Poison Chemotherapy
by: Jingyin Yue, Shijie Lan, Changji Yuan, Zhiyuan Shen
Published: (2012-01-01)

Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison
by: Ulviye Acar Çevik, et al.
Published: (2020-01-01)

Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.
by: Yang Wang, et al.
Published: (2010-04-01)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
by: Caroline Molinaro, et al.
Published: (2020-10-01)

The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning
by: Bruno, Peter M, et al.
Published: (2021)

Transition Metal Intercalators as Anticancer Agents—Recent Advances
by: Krishant M. Deo, et al.
Published: (2016-10-01)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents.
by: Raffaella Cincinelli, et al.
Published: (2018-01-01)

Design and synthesis of novel rigid dibenzo[b,f]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators
by: Mohammed Farrag El-Behairy, et al.
Published: (2023-12-01)

Characterization of Mutations in DNA Gyrase and Topoisomerase IV in Field Strains and In Vitro Selected Quinolone-Resistant <i>Mycoplasma hyorhinis</i> Mutants
by: Jun Li, et al.
Published: (2022-04-01)

Natural variation in a single amino acid substitution underlies physiological responses to topoisomerase II poisons.
by: Stefan Zdraljevic, et al.
Published: (2017-07-01)

Chili pepper extracts, capsaicin, and dihydrocapsaicin as potential anticancer agents targeting topoisomerases
by: Terézia Hudáková, et al.
Published: (2024-02-01)

A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
by: Cosmas O. Okoro, et al.
Published: (2023-01-01)

Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.
by: Malgorzata N Drwal, et al.
Published: (2011-01-01)

Design, Synthesis and Anticancer Evaluation of Substituted Cinnamic Acid Bearing 2-Quinolone Hybrid Derivatives
by: Ali H. Abu Almaaty, et al.
Published: (2021-08-01)

New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies
by: Asmaa H. Mohamed, et al.
Published: (2024-12-01)

A Synthetic Lethal Interaction between APC/C and Topoisomerase Poisons Uncovered by Proteomic Screens
by: Manuel Eguren, et al.
Published: (2014-02-01)

A Yeast-Based Screening System for Differential Identification of Poisons and Suppressors of Human Topoisomerase I
by: Ahmed Seddek, et al.
Published: (2022-03-01)

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation
by: Víctor González-Ruiz, et al.
Published: (2021-10-01)

A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity
by: Zhi-Ying Li, et al.
Published: (2021-11-01)

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade
by: Dipta Dey, et al.
Published: (2022-06-01)

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
by: Yang Xu, et al.
Published: (2015-07-01)

Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme
by: Hadeer K. Swedan, et al.
Published: (2023-12-01)

Development of derivatives of 3, 3'-diindolylmethane as potent Leishmania donovani bi-subunit topoisomerase IB poisons.
by: Amit Roy, et al.
Published: (2011-01-01)

Quinolon Resistance
by: Zeynep GÜLAY
Published: (2002-12-01)

Quinolone Allergy
by: Edoabasi U. McGee, et al.
Published: (2019-07-01)

Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα
by: Ilija N. Cvijetić, et al.
Published: (2023-02-01)